Last reviewed · How we verify
NCT03394235
Optimizing Parameters for Long-pulsed Nd:YAG Laser for Reducing Hair Shaft Diameter
NA trial testing Long-pulsed, 1064nm Nd-YAG laser in Androgenetic Alopecia in 14 participants. Completed in 16 January 2019.
14 November 2018
Quick facts
| Lead sponsor | Institute of Dermatology, Thailand |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 14 |
| Start date | 2 February 2018 |
| Primary completion | 14 November 2018 |
| Estimated completion | 16 January 2019 |
| Sites | 1 location across Thailand |
Drugs / interventions tested
- Long-pulsed, 1064nm Nd-YAG laser
Conditions studied
- Androgenetic Alopecia — all drugs for Androgenetic Alopecia →
- Hair Loss/Baldness — all drugs for Hair Loss/Baldness →
Sponsor
Institute of Dermatology, Thailand
Who can join
Adults 25 to 60, any sex, with Androgenetic Alopecia or Hair Loss/Baldness. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study evaluates the optimizing parameters of long pulse Nd:YAG Laser for reducing the size of hair shaft diameter of the donor for hair transplantation. All participants will receive long-pulsed Nd-YAG laser treatments with three different parameters at the occipital area.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03394235
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Androgenetic Alopecia
Currently open trials in the same condition.
- NCT07429253 — Secretome vs. PRP Injections for Hair Density and Growth in Androgenetic Alopecia Patients · Phase 1, PHASE2 · recruiting
- NCT06841458 — Six-Month Single-Blind, Placebo-Controlled Study of a Dietary Supplement Supplement on Hair Growth in 45 Volunteers · NA · recruiting
Other Institute of Dermatology, Thailand trials
Trials by the same sponsor.
- NCT07536100 — VENEZE Peptide Factor Hair Serum Compared With Topical 2% Minoxidil for Androgenetic Alopecia · NA · not yet recruiting
- NCT07503197 — A Pilot Study on the Efficacy of 2% Cholesterol Cream in Preventing Transepidermal Water Loss and Clinical Symptoms in M · NA · enrolling by invitation
- NCT07433907 — Efficacy of an Antioxidant Moisturizing Serum for Mild to Moderate Seborrheic Dermatitis · NA · recruiting
- NCT06202560 — Effectiveness and Safety of Tofacitinib in Patients With Recalcitrant Frontal Fibrosing Alopecia : A Pilot Study · NA · completed
- NCT05724589 — The Effectiveness of Epidermal Growth Factor Serum in Improve Facial Skin Hydration, Elasticity, Pigmentation, and Wrink · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03394235 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Institute of Dermatology, Thailand
- Last refreshed: 30 January 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03394235.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing